Descriptions

ACTN2 is a major F-actin cross-linking protein in both muscle and non-muscle cells and a major multivalent platform mediating interactions with many cytoskeletal or regulatory proteins. An interaction between the C-terminal region of ACTN2 and the Z-repeat motifs of Titin protein targets ACTN2 to the Z-disk. Full-length ACTN2 does not bind Z-repeats. ACTN2 has a region that acts as a pseudo-Z-repeat between the actin-binding domain (ABD) and the spectrin-like repeats (R1), and this region prevents ACTN2 from binding to the Z-repeat of Titin protein. This autoinhibition is relieved upon binding of the Z-disk lipid phosphatidylinositol-bisphosphate to the ABD of ACTN2.

Autoinhibitory domains (AIDs)

Target domain

752-904 (EF-hand domain)

Relief mechanism

Ligand binding

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q90734

Entry ID Method Resolution Chain Position Source
AF-Q90734-F1 Predicted AlphaFoldDB

No variants for Q90734

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q90734

No associated diseases with Q90734

11 regional properties for Q90734

Type Name Position InterPro Accession
conserved_site Actinin-type actin-binding domain, conserved site 45 - 54 IPR001589-1
conserved_site Actinin-type actin-binding domain, conserved site 119 - 143 IPR001589-2
domain Calponin homology domain 43 - 147 IPR001715-1
domain Calponin homology domain 156 - 262 IPR001715-2
repeat Spectrin repeat 286 - 395 IPR002017-1
repeat Spectrin repeat 406 - 510 IPR002017-2
repeat Spectrin repeat 523 - 632 IPR002017-3
repeat Spectrin repeat 643 - 744 IPR002017-4
domain EF-hand domain 758 - 834 IPR002048
domain EF-hand, Ca insensitive 834 - 900 IPR014837
repeat Spectrin/alpha-actinin 289 - 747 IPR018159

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Cell junction
  • Cytoplasm, perinuclear region
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
cell junction A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella.
cell projection A prolongation or process extending from a cell, e.g. a flagellum or axon.
cortical actin cytoskeleton The portion of the actin cytoskeleton, comprising filamentous actin and associated proteins, that lies just beneath the plasma membrane.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
Z disc Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached.

3 GO annotations of molecular function

Name Definition
actin filament binding Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits.
calcium ion binding Binding to a calcium ion (Ca2+).
nuclear receptor coactivator activity A transcription coactivator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound nuclear receptor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator.

6 GO annotations of biological process

Name Definition
actin cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
muscle cell development The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate.
peroxisome proliferator activated receptor signaling pathway The series of molecular signals initiated by binding of a ligand to any of the peroxisome proliferator activated receptors (alpha, beta or gamma) in the nuclear membrane, and ending with the initiation or termination of the transcription of target genes.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
retinoic acid receptor signaling pathway The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands.

17 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3ZC55 ACTN2 Alpha-actinin-2 Bos taurus (Bovine) SS
Q3B7N2 ACTN1 Alpha-actinin-1 Bos taurus (Bovine) SS
Q0III9 ACTN3 Alpha-actinin-3 Bos taurus (Bovine) SS
A5D7D1 ACTN4 Alpha-actinin-4 Bos taurus (Bovine) SS
P05094 ACTN1 Alpha-actinin-1 Gallus gallus (Chicken) SS
P20111 ACTN2 Alpha-actinin-2 Gallus gallus (Chicken) SS
P18091 Actn Alpha-actinin, sarcomeric Drosophila melanogaster (Fruit fly) SS
P12814 ACTN1 Alpha-actinin-1 Homo sapiens (Human) SS
Q08043 ACTN3 Alpha-actinin-3 Homo sapiens (Human) SS
P35609 ACTN2 Alpha-actinin-2 Homo sapiens (Human) EV
O43707 ACTN4 Alpha-actinin-4 Homo sapiens (Human) SS
O88990 Actn3 Alpha-actinin-3 Mus musculus (Mouse) SS
Q7TPR4 Actn1 Alpha-actinin-1 Mus musculus (Mouse) SS
Q9JI91 Actn2 Alpha-actinin-2 Mus musculus (Mouse) SS
P57780 Actn4 Alpha-actinin-4 Mus musculus (Mouse) SS
Q9Z1P2 Actn1 Alpha-actinin-1 Rattus norvegicus (Rat) SS
Q9QXQ0 Actn4 Alpha-actinin-4 Rattus norvegicus (Rat) SS
10 20 30 40 50 60
MVDYHSAGQP YPYGGNGPGP NGDYMAQEDD WDRDLLLDPA WEKQQRKTFT AWCNSHLRKA
70 80 90 100 110 120
GTQIENIDED FRDGLKLMLL LEVISGERLP KPERGKMRVH KINNVNKALD FIASKGVNVV
130 140 150 160 170 180
SIGAEEIVDG NAKMTLGMIW TIILRFAIQD ISVEETSAKE GLLLWCQRKT APYKNVNVQN
190 200 210 220 230 240
FHISWKDGLA FNALIHRHRP ELIEYDKLRK DDPVTNLNNA FEVAEKYLDI PKMLDAEDIV
250 260 270 280 290 300
NTARPDEKAI MTYVSSFYHA FSGAQKAETA ANRICKVLAV NQENEHLMED YEKLASDLLE
310 320 330 340 350 360
WIRRTIPWLE DRSPQKTIQE MQQKLEDFRD YRRVHKPPKV QEKCQLEINF NTLQTKLRLS
370 380 390 400 410 420
NRPAFMPSEG RMVSDINTGW QHLEQAEKGY EEWLLNEIRR LEPLDHLAEK FRQKASIHEA
430 440 450 460 470 480
WTEGKEAMLK QKDYETATLS DIKALIRKHE AFESDLAAHQ DRVEQIAAIA QELNELDYYD
490 500 510 520 530 540
SPSVNARCQK ICDQWDVLGS LTHSRREALE KTEKQLETID ELHLEYAKRA APFNNWMESA
550 560 570 580 590 600
MEDLQDMFIV HTIEEIEGLI AAHDQFKATL PDADREREAI LGIQREAQRI ADLHSIKLSG
610 620 630 640 650 660
NNPYTSVTPQ VINSKWERVQ QLVPTRDRAL QDEQSRQQCN ERLRRQFAGQ ANIVGPWMQT
670 680 690 700 710 720
KMEEIGRISI EMHGTLEDQL QHLKHYEQSI VDYKPNLELL EHEHQLVEEA LIFDNKHTNY
730 740 750 760 770 780
TMEHIRVGWE QLLTTIARTI NEVENQILTR DAKGISQEQM QEFRASFNHF DKDHCGALGP
790 800 810 820 830 840
EEFKACLISL GYDVENDRQG DAEFNRIMSL VDPNGSGSVT FQAFIDFMSR ETTDTDTADQ
850 860 870 880 890 900
VIASFKVLAG DKNYITAEEL RRELPPEQAE YCIARMAPYR GPDAAPGALD YKSFSTALYG
ESDL